🌟 Interesting to read! 🌟 Read the first blog by the Oncode Accelerator team on the network of the Federation of European Biochemical Societies (FEBS). The blog will give you more insight about the Innovation Platforms and Workstreams within the program and our first call for Demonstrator Projects. Read the blog via the link below 👇 #FEBS #CancerResearch #Innovation
Do you work in the development of preclinical cancer therapies? The Oncode Accelerator program has an open call for Demonstrator Projects. They offer access to state-of-the-art equipment, expertise, facilities and technologies towards the development of cancer therapies up to early clinical validation. Their aim is to eventually turn assets into de-risked clinical candidates. Demonstrator Projects applicants may be eligible for up to 50% co-funding (maximum of €1.5 million per Demonstrator Project). The Oncode Accelerator program is a network of public and private partnerships from the Netherlands, including Leiden University, Leiden University Medical Center, the The Netherlands Cancer Institute, Princess Máxima Center, UMC Utrecht and the Oncode Accelerator Foundation. They receive funding from the Dutch National Growth Fund. Find out more on this FEBS Network post: https://lnkd.in/d8dXKipY